Sun Pharma
Search results
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.
Cipla is a leading pharmaceutical company that provides affordable medicine to patients across geographies. Over the last 8 decades, we have been fortifying our promise of ‘Caring for Life'.
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the...
6 days ago · Cipla has “completely professionalised” over the last 10 years, said Cipla Managing Director and Global Chief Executive Umang Vohra, of a transformative journey undertaken even as two of its ...
Make every life thrive. You will be inspired by our purpose and pioneering spirit at Cipla. Growth, to us, is meaningful when it is holistic and has an impact beyond ourselves. Inspiring Pioneers. Championing Care. Nourishing Careers. Search jobs.
1 day ago · Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. Explore the latest updates on Cipla stock, including: Last traded price 1512.1, Market capitalization: 122077.94, Volume: 1507, Price-to-earnings ratio 29.62, Earnings per share 51.05. Our liveblog combines fundamental and technical insights to offer a comprehensive overview of Cipla's performance. Gain valuable market knowledge and make informed decisions with our ...
2 days ago · Cipla Limited Stock Price Today, Live NSE Share Price: Get the latest Cipla Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Oct 27, 2023 · BENGALURU, Oct 27 (Reuters) - Cipla (CIPL.NS), India's third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength in its...
Jul 4, 2024 · Cipla’s success in the US market is a significant growth driver. This success is attributed to new product launches, seasonal factors, and a strong market position in key assets.
